Latest California Healthline Stories
Report: Fired U.S. Attorney Was Probing Tom Price’s Stock Trades
The HHS Secretary bought stock in companies that stood to benefit from legislation he voted for and sponsored as a Georgia congressman.
Top Research Centers Call Trump’s Proposed NIH Cuts ‘Shocking’
Research institutions that stand to lose the most include UCSF, Stanford University and UC San Diego. Total NIH funding for the University of California system reached nearly $2 billion in fiscal year 2016.
By The Numbers: Trump’s Choice For FDA Chief Is Versatile And Entrenched In Pharma
The numbers show that President Trump’s choice for FDA commissioner, Scott Gottlieb, has long-standing ties to pharmaceutical companies as a board member or consultant and that he had to recuse himself multiple times while working at the FDA.
Families To Pay Price If Maternity Care Coverage Is Cut By GOP
Before the health law, buying an individual policy that included coverage for pregnancy and labor was extremely difficult.
Deciphering The CBO Estimates On The GOP Health Bill
The federal government’s budget experts estimate that the Republican plan would reduce the deficit but dramatically drive up the number of uninsured.
GOP Health Plan Could Be Bitter Pill For California’s Obamacare Exchange
Critics say the proposed changes could poison one of the nation’s healthiest marketplaces, driving up premiums and drawing in only the sickest patients. Republicans and industry analysts call those concerns overblown.
Trump, Dems Look For Common Ground On Drug Prices
Two Democratic congressmen met with President Trump to seek his support for a bill to expand the government’s ability to negotiate drug prices, but it’s not clear it would have much impact or will gain support.
Video Highlights: Trump Promises To Lower Cost Of Health Insurance
President Trump called on Republicans and Democrats to work together to repeal and replace Obamacare.
President Trump And I Take The Same Drugs — Except One
An aging writer discovers there are worse things than going bald after examining the side effects of a popular hair loss drug purportedly used by President Donald Trump.
A New Diagnosis: ‘Post-Election Stress Disorder’
Trump opponents — and even some supporters — say the election and tumultuous early days of the new administration have left them anxious, angry and afraid of Facebook.